July 2024

Face-specific identification impairments following sight-providing treatment may be alleviated by an initial period of low visual acuity.

Gilad-Gutnick S, Hu HF, Dalrymple KA, Gupta P, Shah P, Ralekar C, Verma D, Tiwari K, Ben-Ami S, Swami P, Ganesh S, Mathur U, Sinha P. Face-specific identification impairments following sight-providing treatment may be alleviated by an initial period of low visual acuity. Sci Rep. 2024 Jul 29;14(1):17374. doi: 10.1038/s41598-024-67949-z. PMID: 39075093; PMCID: PMC11286960.

Brolucizumab-associated intraocular inflammation in Indian patients by VRSI study group.

Agarwal M, Muralidhar A, Shanmugam MP, Kothari A, Dudani A, Maiti A, Arora A, Jayadev C, Gupta C, Shroff D, Chakraborty D, Pillai GS, Lahiri K, Verma L, Gopalakrishnan M, Narayanan R, Mishra SK, Patil S, Choudhary S, Chakraborty S, Natesh S, Koundanya V, Aggarwal V. Brolucizumab-associated intraocular inflammation in Indian patients by VRSI study group. Indian J Ophthalmol. 2024 Aug 1;72(8):1156-1161. doi:10.4103/IJO.IJO_2973_23. Epub 2024 Jul 29. PMID:
39078959.

Awareness, knowledge and challenges faced by beneficiaries and non-beneficiaries of Ayushman Bharat–Pradhan Mantri Jan Arogya Yojana with special reference to eyecare in three districts of Uttar Pradesh state: A cross-sectional study.

Sabherwal S, Sood I, Khurana A, Chauhan L, Saini S, Shroff K, Majumdar A. Awareness, knowledge and challenges faced by beneficiaries and non-beneficiaries of Ayushman Bharat–Pradhan Mantri Jan Arogya Yojana with special reference to eyecare in three districts of Uttar Pradesh state: A cross-sectional study. Journal of Family Medicine and Primary Care. 2024 Jul;13(8):2892-9. 10.4103/jfmpc.jfmpc_1678_23.